CBS News reports on growing safety concerns regarding doctors prescribing retatrutide, an experimental weight loss drug that has not yet received approval from the Food and Drug Administration (FDA).
Bias read (Center): The article presents a factual report on safety concerns related to an unapproved drug without taking a stance or using biased language. It does not favor any particular political perspective.
Official sources cited
- government Food and Drug Administration (FDA)